Secure IBD

SECURE-IBD is an international database that captured the natural history and outcomes of #COVID19 occurring in #IBD patients from March 2020 to January 2022.

[Secure IBD @SecureIBD]

Our analysis on the impact of #IBD medications in >6000 patients with #COVID19 in our registry is out in @AGA_Gastro!

[Ryan Ungaro MD MS @ryanungaro]

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry. Latest from SECURE-IBD. https://t.co/VyNQsyymci

[Secure IBD @SecureIBD]

@EJBrenner_MD @ManasiAgrawalMD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @IOIBD1 @CrohnsColitisFn @NASPGHAN @Y_ECCO_IBD

[Secure IBD @SecureIBD]

It is time to close down reporting to the SECURE-IBD database. We are proud of SECURE-IBD’s contributions and incredibly grateful for your help. This initiative was not possible without the support of the entire #IBD community.

https://t.co/fAA7yvhQPM

[Uma Mahadevan @UmaMahadevanIBD]

Great talk by ⁦@ryanungaro⁩ ⁦@SecureIBD⁩ on COVID-IBD. Disease activity and steroids biggest risk factors for poor outcomes. ⁦@ucsfibd⁩

[Secure IBD @SecureIBD]

The strength of collaboration!
Study pooling data on TNFi +/- other therapies and #COVID19 outcomes in >6000 patients with immune-mediated inflammatory diseases
@rheum_covid @PsoProtect

[JAMA Network Open @JAMANetworkOpen]

Pooled results from @rheum_covid, @SecureIBD, and @PsoProtect, representing >6000 patients with immune-mediated inflammatory disease and #COVID19, support TNFi monotherapy use during the pandemic. @IzadiZara @EJBrenner_MD @JYazdanyMD @MichaelKappel12 https://t.co/SyXjrVXMSC

[Secure IBD @SecureIBD]

Great collaboration with @amandaricciuto @ericbenchimol @DrNickKennedy @ibdseb and others!

[Eric Benchimol @ericbenchimol]

New @SecureIBD study from @amandaricciuto at @SickKidsNews IBD Centre: younger patients w.more severe inflammation at-risk for severe #COVID19 (controlling for medications) @gilkaplan @MichaelKappel12 @ManasiAgrawalMD @EJBrenner_MD @ekuenzig @DrNickKennedy https://t.co/oIbFSHTKJW

[Secure IBD @SecureIBD]

New GI symptoms in individuals with #IBD who get #COVID19 do not correlate with death or other severe outcomes.

Read our new pub here 👉🏻
https://t.co/LSJgxClbex

@ryanungaro @ManasiAgrawalMD @EJBrenner_MD @MichaelKappel12 @JeanFredericCo1

[Gastroenterology Learning Network @Gastro_Network]

@EJBrenner_MD and @ManasiAgrawalMD on #COVID19 outcomes and racial disparities among #IBD populations
🔊https://t.co/m6cruIcVyH

@SecureIBD @wingyanjoyce @gilkaplan @Siew_C_Ng @Flaviostein @JamesLewisGIEpi @HuntKissous @IreneModesto @ryanungaro @JeanFredericCo1 @MichaelKappel12

[Secure IBD @SecureIBD]

Rajen Parekh, a recent high school graduate, reported on the impact of individual comorbid conditions on #COVID19 outcomes in #IBD @DDS_Journal
What an accomplishment!
https://t.co/gxPBzoM1lB

@EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12

[Secure IBD @SecureIBD]

@ManasiAgrawalMD @EJBrenner_MD on our study on racial ethnic disparities in #COVID19 outcomes in #IBD @medpagetoday https://t.co/KiQaOyhF8g
@wingyanjoyce @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @HuntKissous @IreneModesto

[Secure IBD @SecureIBD]

@ManasiAgrawalMD @EJBrenner_MD @wingyanjoyce @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @JeanFredericCo1 @MichaelKappel12

[Secure IBD @SecureIBD]

Disparities in #COVID19 outcomes by race and ethnicity, now published in @AGA_CGH
➡️Hispanic & non-Hispanic black individuals with #IBD had worse #COVID19 outcomes
➡️driven in part by non-IBD comorbidities
https://t.co/l9hElm9OC9

[Secure IBD @SecureIBD]

➡️a reminder to take into account social determinants of health in clinical practice
➡️emphasizes the urgent need for policy change towards equitable healthcare for all

Health is a human right.

[Neera Gupta, MD, MAS @NeeraGuptaMD]

Dr @MichaelKappel12 discussing Outcomes in Patients with #IBD and #COVID19 by Age #DDW21 #DDW2021 @secureIBD

[Secure IBD @SecureIBD]

NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN... by @ryanungaro
DDW ePoster Library; May 21 2021; 319648
https://t.co/nx3eYbdTYB
@EJBrenner_MD @ManasiAgrawalMD @MichaelKappel12 @JeanFredericCo1

[Secure IBD @SecureIBD]

COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC... by @EJBrenner_MD
DDW ePoster Library; May 21 2021; 319659
Poster of Distinction!
https://t.co/oWsSA8rTwP
@ManasiAgrawalMD @ryanungaro @wingyanjoyce @Siew_C_Ng @gilkaplan @JeanFredericCo1 @MichaelKappel12

[Secure IBD @SecureIBD]

THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19... by @ManasiAgrawalMD
DDW ePoster Library; May 21 2021; 319644
https://t.co/iMTM4JnbhF
@EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1

[Secure IBD @SecureIBD]

THE EFFECTS OF COMORBIDITIES ON COVID-19... by Rajen Parekh
DDW ePoster Library; May 21 2021; 319646
https://t.co/LoQVwPY9n2
@EJBrenner_MD @MichaelKappel12 @ryanungaro @ManasiAgrawalMD @JeanFredericCo1

[Millie Long @MLongMD]

We are pleased to report that we have hit the 3000 mark in IBD patients enrolled in PREVENT COVID (a study of COVID-19 vaccination). Our team pledges to share results with patients in real time. Check out preliminary results here (>90% with titers) https://t.co/JyShIQX3wI

[Secure IBD @SecureIBD]

@ManasiAgrawalMD @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1

[Secure IBD @SecureIBD]

Read our paper on VDZ outcomes in #IBD, out in JCC
@Y_ECCO_IBD

👉🏻Compared to all other meds, VDZ use was not a/w hospitalization or severe #COVID19
👉🏻Compared to TNFi monotherapy, VDZ monotherapy was a/w hospitalization, but not severe #COVID19
https://t.co/Fuq9gUIG35